← Back to Search

Health Linkage for Opioid Use Disorder

N/A
Waitlist Available
Led By April M Young, PhD, MPH
Research Sponsored by University of Kentucky
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up assessed at 3 months and 6 months after the baseline, change at 3 months reported
Awards & highlights

Study Summary

This trial will study the effects of an intervention to help reduce substance use and related harms among people leaving rural jails or who are otherwise involved in the criminal justice system. The intervention will be compared with those who will only receive overdose education. The study will collect surveys and overdose education from all participants. Some participants will be chosen at random to be in the intervention group or the comparison group. The investigators hope to learn if providing linkage to health services, HIV, hepatitis C virus (HCV), and overdose education to people leaving rural jails or who are otherwise involved in the criminal justice system will reduce substance use and related harms.

Eligible Conditions
  • Opioid Use Disorder
  • Substance Abuse
  • Human Immunodeficiency Virus Infection
  • Hepatitis C
  • Sexually Transmitted Diseases
  • Drug Overdose

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~assessed at 3 months and 6 months after the baseline, change at 3 months reported
This trial's timeline: 3 weeks for screening, Varies for treatment, and assessed at 3 months and 6 months after the baseline, change at 3 months reported for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Substance Use Frequency
Secondary outcome measures
Change in Engagement in HCV Risk Behaviors - Receptive Syringe Sharing
Change in Engagement in HCV Risk Behaviors - Shared Injection Equipment
Change in Engagement in HIV Risk Behaviors - Condomless Sex
+10 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Overdose EducationExperimental Treatment1 Intervention
The investigators will initiate the comparison group in Group 2 counties six months before the intervention begins. Research staff will conduct an overdose intervention with the comparison cohort. This will occur pre-release if individual is recruited in jail. The comparison group participants will watch a video on preventing, recognizing, and responding effectively to an opioid OD, accompanied by information about Kentucky's Good Samaritan Law and Naloxone Access Law. Research staff will answer questions after the video. Individuals will receive a Community Resource Guide at this visit. As in the intervention group, the comparison group participants will complete surveys at the baseline (in jail if recruited in jail, in a community setting if recruited in the community), and at 3 months and 6 months after the baseline. Surveys will be identical to those delivered to the intervention cohort.
Group II: Health LinkageExperimental Treatment2 Interventions
Research staff will: 1) meet with participants in person or virtually to ask questions about drug use and related behaviors, service access, and personal goals; provide overdose education and help develop a plan for reducing risks and accessing services; conduct drug testing, offer HIV and HCV testing and counseling, naloxone, and harm reduction supplies, and connection with needed services; 2) follow up with participants monthly for three months to help overcome challenges; and 3) six months post-enrollment, contact participants to conduct drug testing. Participants will complete surveys at baseline, 3 months, and 6 months
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Overdose Education
2019
N/A
~240
Health Linkage
2019
N/A
~240

Find a Location

Who is running the clinical trial?

Centers for Disease Control and PreventionFED
878 Previous Clinical Trials
22,479,390 Total Patients Enrolled
University of KentuckyLead Sponsor
187 Previous Clinical Trials
225,915 Total Patients Enrolled
Emory UniversityOTHER
1,646 Previous Clinical Trials
2,564,366 Total Patients Enrolled
~43 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top